Merck's HIV treatment meets main goal of two late-stage studies
|
GILD triple-combination tablet Biktarvy and various other antiretroviral
therapies in suppressing replication of the virus, the company said. |
Why scientists want people living with HIV to start using climate-friendly ARVS
... antiretroviral (ARV) largely used in Kenya that they say is not climate-friendly due to high greenhouse gas (GHG) emissions. Speaking to Healthy ... View article...